
United States Food and Drug Administration, Urinary Tract Infections, Humans, Thienamycins, Meropenem, Microbial Sensitivity Tests, Drug Approval, United States, Anti-Bacterial Agents, Randomized Controlled Trials as Topic
United States Food and Drug Administration, Urinary Tract Infections, Humans, Thienamycins, Meropenem, Microbial Sensitivity Tests, Drug Approval, United States, Anti-Bacterial Agents, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
